Option Care Health, Inc. OPCH

Full chart Compare
Set alert

Price alert · OPCH

All alert types
31.70 USD +0.05 (+0.16%)

Nov 5, 2026, 12:44 PM EST

31.67 Day range 31.79
18.01 52-week range 36.80
YTD
-0.50%
1 year
+17.06%
Market cap
4.75B
Revenue (ttm)
5.69B
Profit margin
3.68%
EPS (ttm)
1.38
Shares out
149.79M
P/E ratio
22.97
Forward P/E
15.20
YTD return
-0.50%
1-year return
+17.06%
Volume
1.75M
Avg volume
3.96M
Open
31.72
Previous close
31.65
Day's range
31.67 – 31.79
52-week range
18.01 – 36.80
Beta
0.46
Analysts
Hold
Price target
30.03 (-5.3%)
Earnings date
Feb 23, 2027

2Y +9.38 (+42.03%)

20253035Jan 25Jun 25Nov 25Apr 26Aug 2631.70

Key statistics

Enterprise value
5.83B
PEG ratio
1.53
Price / sales
0.83
Price / book
3.76
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
1.90%
Free cash flow
256.07M
Total cash
196.78M
Total debt
1.27B
Return on equity
16.00%
Short % of float
6.62%
50-day average
26.83
200-day average
26.28

Financials — quick view

All financials
OPCH Revenue — quarterly 1.49B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
OPCH Net income — quarterly 57.43M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
OPCH EPS — quarterly 0.38
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

OPCH recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 23, 2027Dec 30, 20260.54———
Nov 4, 2026Sep 30, 20260.48940.490.00+0.12%
Jul 29, 2026Jun 30, 20260.42630.45+0.02+5.56%
Apr 30, 2026Mar 31, 20260.370.40+0.03+8.11%
Feb 24, 2026Dec 31, 20250.460.460.000.00%
Oct 30, 2025Sep 30, 20250.430.45+0.02+4.65%

Upgrades / downgrades

OPCH analyst upgrades and downgrades
DateFirmActionFromTo
Oct 9, 2026UBSdownBuyNeutral
Oct 7, 2026William BlairdownOutperformMarket Perform
Oct 7, 2026JP MorgandownOverweightNeutral
Oct 7, 2026CitizensdownMarket OutperformMarket Perform
Oct 7, 2026JefferiesdownBuyHold
Oct 7, 2026Barrington ResearchdownOutperformMarket Perform

About Option Care Health, Inc.

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.

Sector
Healthcare
Industry
Medical Care Facilities
Country
United States

News

Your note

Sign in to keep a note on OPCH — it syncs with the Stock Master app.

Insider holders

OPCH insider holders
InsiderRelationLatest transactionDateShares held
BHATIA PRATEEKOfficerStock Award(Grant)Jul 5, 202639,795
GOLDING DAVID WDirectorPurchaseAug 20, 2025116,525
GRASHOFF CHRISTOPHER LOfficerStock Award(Grant)Feb 17, 202648,558
KRAEMER HARRY M. JANSEN JR.DirectorStock Award(Grant)May 19, 2026471,076
RADEMACHER JOHN CHARLESChief Executive OfficerPurchaseMay 3, 2026695,152
SETHNA MEENALChief Financial OfficerPurchaseMay 3, 202698,337

Institution ownership

OPCH institution ownership
Holder% heldSharesValueReported
Blackrock Inc.14.76%22,104,863699.62MJun 29, 2026
Wellington Management Group, LLP7.87%11,782,384372.91MJun 29, 2026
Vanguard Portfolio Management LLC5.52%8,274,458261.89MJun 29, 2026
Fuller & Thaler Asset Management Inc.4.97%7,450,698235.81MJun 29, 2026
Vanguard Capital Management LLC4.72%7,063,747223.57MJun 29, 2026
Durable Capital Partners Lp4.12%6,163,722195.08MJun 29, 2026

Fund ownership

OPCH fund ownership
Holder% heldSharesValueReported
Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund4.78%7,157,244226.53MJun 29, 2026
VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund4.51%6,748,598213.59MJul 30, 2026
iShares Trust-iShares Core S&P Mid-Cap ETF3.56%5,330,070168.70MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.32%4,979,416157.60MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.76%4,132,775130.80MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund2.41%3,604,513114.08MJun 29, 2026